HELX

Franklin Genomic Advancements ETF · BATS

Category Equity
Expense Ratio 0.5%
Listing Date Feb 27, 2020
Volume 525.0
Market Cap (AUM) $10.23M

Performance

-5.06%

-9.65%

-12.6%

-7.65%

-4.03%

YTD

+6.09%

Top Holdings

Name
Symbol
%Assets
Medpace Holdings, Inc.MEDP6.95%
Vertex Pharmaceuticals IncorporatedVRTX5.51%
Regeneron Pharmaceuticals, Inc.REGN5.14%
Danaher CorporationDHR5.11%
Thermo Fisher Scientific Inc.TMO4.75%
Eli Lilly and CompanyLLY4.69%
Krystal Biotech, Inc.KRYS4.36%
Natera, Inc.NTRA3.49%
Astrazeneca PLC Sponsored ADRAZN2.74%
SAMSUNG BIOLOGICS Co., Ltd.2079402.73%

Advanced Technical Analysis

Technical Analysis of HELX 2024-11-20

The Moving Average Score of 10 indicates a strong bearish sentiment, while the Oscillators Score of 56 suggests a neutral stance. Overall, the Technical Score of 33 reinforces the bearish outlook, indicating that the stock may face downward pressure in the near term.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Recent News & Updates

2021-07-15 23:19
Blockchain will be hugely disruptive to the finance industry: Jenny Johnson(Yahoo Finance)
2021-01-13 20:15
Franklin Adds To Thematic ETF Line(Yahoo Finance)
2020-10-04 20:00
Franklin Templeton Gives Matt Moberg Three New Funds To Run(Investors)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.